Follow-up on the cosmetic surgery review
As many of you are aware the cosmetic surgery industry has been under review for the last two months. The British Association of Aesthetic Plastic Surgeons (BAAPS) has now put forward their findings to the government, which has come from professionals and patients.
BAAPS has proposed that dermal fillers should be classed as medicines, so they would like to regulate what comes on the market once it has been tested, this means they would ban advertising as dermal fillers would be a "Medicine".
Define who is aloud to perform non-surgical cosmetic procedures; this would have to be addressed by the EU standards, but regulation of non-surgical procedures should be mandatory and run by an independent entity like the Care Quality Commission.
There should be an audit of procedures and complications to aid revalidation and enable it to promote clinical governance. BAAPS have also requested that records and note keeping is kept for non-surgical procedures as it is for surgical procedures.
BAAPS have requested that for surgical procedures, the term "Surgeon" should only be used for someone who is on the Specialist Register for a surgical specialty. Surgeons who can perform which procedure should be decided in accordance with CEN guidance to be released in 2013.
Surgeons from abroad should have UK-based insurance, so patients who need legal help can fight a claim for negligence. Implants will undergo pre market testing and post market monitoring. Also they have requested a national breast implant register so prostheses are monitored and records are kept.
Patients will also be protected as the consent process will involve a consultation with the surgeon for at least 30 minutes and a follow up if required as well as cooling off period and psychological assessment will be available.
Cosmetic surgery advertising will be banned as well as unethical marketing practices such as buy one get one free offers. There will also be an insurance scheme for patients to help them if an implant is faulty so they can have it removed and replaced.
The BAAPS President Rajiv Grover and consultant plastic surgeon stated,"The call for evidence by the Keogh review has given our sector an ideal platform to air issues that have long been concerning many of us. The PIP implants crisis demonstrated beyond a shadow of a doubt that there are clear failures in the system, as well as vulnerable people being taken advantage of. It may not be possible to prevent criminal activity in the future, but certainly safeguards can be put in place to protect the public as much as possible."
BAAPS has proposed that dermal fillers should be classed as medicines, so they would like to regulate what comes on the market once it has been tested, this means they would ban advertising as dermal fillers would be a "Medicine".
Define who is aloud to perform non-surgical cosmetic procedures; this would have to be addressed by the EU standards, but regulation of non-surgical procedures should be mandatory and run by an independent entity like the Care Quality Commission.
There should be an audit of procedures and complications to aid revalidation and enable it to promote clinical governance. BAAPS have also requested that records and note keeping is kept for non-surgical procedures as it is for surgical procedures.
BAAPS have requested that for surgical procedures, the term "Surgeon" should only be used for someone who is on the Specialist Register for a surgical specialty. Surgeons who can perform which procedure should be decided in accordance with CEN guidance to be released in 2013.
Surgeons from abroad should have UK-based insurance, so patients who need legal help can fight a claim for negligence. Implants will undergo pre market testing and post market monitoring. Also they have requested a national breast implant register so prostheses are monitored and records are kept.
Patients will also be protected as the consent process will involve a consultation with the surgeon for at least 30 minutes and a follow up if required as well as cooling off period and psychological assessment will be available.
Cosmetic surgery advertising will be banned as well as unethical marketing practices such as buy one get one free offers. There will also be an insurance scheme for patients to help them if an implant is faulty so they can have it removed and replaced.
The BAAPS President Rajiv Grover and consultant plastic surgeon stated,"The call for evidence by the Keogh review has given our sector an ideal platform to air issues that have long been concerning many of us. The PIP implants crisis demonstrated beyond a shadow of a doubt that there are clear failures in the system, as well as vulnerable people being taken advantage of. It may not be possible to prevent criminal activity in the future, but certainly safeguards can be put in place to protect the public as much as possible."
Source...